Literature DB >> 8872899

Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia.

R A Washington1, B Becher, R Balabanov, J Antel, P Dore-Duffy.   

Abstract

The ability of microglia to migrate through central nervous system (CNS) tissue requires proteolytic degradation of components of the extracellular matrix. Urokinase plasminogen activator (uPA), when bound to its cell surface receptor (uPAR), is an active cell surface protease. uPAR expression has been associated with cell activation. Cultured human microglia express surface uPAR. uPAR expression was found to be associated predominately with spindle- or bipolarshaped microglia. The addition of lipopolysaccharide (LPS) to microglial cultures enhanced the proportion of uPAR expression and shifted cell morphology to the elongated spindle or bipolar shape. When microglia were examined immediately ex vivo, uPAR surface expression could not be detected. Similarly, uPAR transcripts detected by reverse transcription-polymerase chain reaction techniques were found in cultured, but not ex vivo, microglia. Microglia isolated from a patient with multiple sclerosis (MS) displayed a large amount of uPAR+ cells. These cells were predominantly spindle or bipolar in nature. These findings suggest that uPAR surface expression is associated with microglial activation. Surface expression of uPAR and associated cell surface protease activity may provide a mechanism for microglial migration and may be important in the pathophysiology of MS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872899     DOI: 10.1002/(SICI)1097-4547(19960815)45:4<392::AID-JNR8>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9.

Authors:  Sun Mi Shin; Kyu Suk Cho; Min Sik Choi; Sung Hoon Lee; Seol-Heui Han; Young-Sun Kang; Hee Jin Kim; Jae Hoon Cheong; Chan Young Shin; Kwang Ho Ko
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

2.  Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

Authors:  R Balabanov; D Lisak; T Beaumont; R P Lisak; P Dore-Duffy
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Fibrinolytic cross-talk: a new mechanism for plasmin formation.

Authors:  Tiphaine Dejouvencel; Loïc Doeuvre; Romaric Lacroix; Laurent Plawinski; Françoise Dignat-George; H Roger Lijnen; Eduardo Anglés-Cano
Journal:  Blood       Date:  2009-12-07       Impact factor: 22.113

4.  CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.

Authors:  D Obregon; H Hou; Y Bai; W V Nikolic; T Mori; Deyan Luo; J Zeng; J Ehrhart; F Fernandez; D Morgan; B Giunta; T Town; J Tan
Journal:  Neurobiol Dis       Date:  2007-10-16       Impact factor: 5.996

5.  A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.

Authors:  Emma East; David Baker; Gareth Pryce; H Roger Lijnen; M Louise Cuzner; Djordje Gverić
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 6.  Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.

Authors:  Manuel Yepes; Yena Woo; Cynthia Martin-Jimenez
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

7.  The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.

Authors:  Devorah Gur-Wahnon; Tehila Mizrachi; Florence-Yehudith Maaravi-Pinto; Athanasis Lourbopoulos; Nikolaos Grigoriadis; Abd-Al Roof Higazi; Talma Brenner
Journal:  J Neuroinflammation       Date:  2013-10-11       Impact factor: 8.322

Review 8.  Genome-Wide Multiple Sclerosis Association Data and Coagulation.

Authors:  Sara La Starza; Michela Ferraldeschi; Maria Chiara Buscarinu; Silvia Romano; Arianna Fornasiero; Rosella Mechelli; Renato Umeton; Giovanni Ristori; Marco Salvetti
Journal:  Front Neurol       Date:  2019-02-14       Impact factor: 4.003

9.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

Review 10.  Alzheimer's Disease Research Using Human Microglia.

Authors:  Lih-Fen Lue; Thomas G Beach; Douglas G Walker
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.